Joseph Anaya, MD, and Ashkan Abbey, MD, discuss how retina specialists identify appropriate candidates for complement inhibitor therapy in geographic atrophy, set patient expectations, and monitor ...
Romania will be the first country where Orange will test the viability of D2D (Direct-to-Device) satellite connectivity, the company announced on Monday, March 2. The test comes after the signing of a ...
This legislation provides for the introduction of a regulated ridesharing service designed to augment and complement Bermuda’s existing taxi industry,” Minister of Tourism & Transport, Culture & Sport ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...
– Data Support the Study of RLYB116 as a Potential Best-In-Class Therapeutic for Multiple Complement Mediated Diseases – – Initiation of RLYB116 Phase 2 Clinical Trial in Immune Platelet Transfusion ...
A fundamental divide between data engineering and business analytics complicates how organizations operate in a rapidly evolving digital environment. Enterprises manage unprecedented volumes of ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results